PHILIPS NV |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.99 EUR | +36.69% |
|
+41.48% | +28.20% |
| 11:01am | European shares hit two-week high; inflation data, Fed meeting in focus | RE |
| 10:03am | PHILIPS NV : Receives a Buy rating from Goldman Sachs | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Calendar
10:30am
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
19.74
EUR
Average target price
20.36
EUR
Spread / Average Target
+3.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +28.20% | 19.11B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +2.28% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Philips : Secures US FDA Nod to Begin Rework of Sleep, Respiratory Devices
